NeuroQuant® Software Accurately Measures Brain Atrophy
Advanced Radiology is excited to offer a new tool to improve the early detection and treatment of dementia and Alzheimer’s Disease (AD). This new MRI software, called NeuroQuant®, precisely measures the brain atrophy (shrinkage) by measuring the size of the hippocampus and other brain structures that typically deteriorate with these disorders. This information helps doctors make a diagnosis and follow the progression of the disease.
The NeuroQuant® software evaluates the patient’s MRI for brain atrophy and compares the results to an FDA-approved database of people of the same age that have healthy brains. It can help provide an early warning for patients who have Mild Cognitive Impairment (MCI). Studies have found that patients who have a small hippocampus are four times more likely to progress to AD in a few years than patients whose hippocampus is a normal size. The hippocampus in a healthy patient shrinks at about 1% per year, compared to about 5% per year in a person with AD.
NeuroQuant® can monitor changes in the atrophy over time to determine if and how quickly the disease is progressing. It also may help to measure the impact of treatments and identify those patients most likely to benefit from aggressive intervention.
Although normal-sized brain structures can’t rule out dementia, high-functioning patients concerned about mild, but increasing, memory loss are likely to be reassured by results in the normal range.
For more information on NeuroQuant®, visit www.cortechs.net.
NeuroQuant® MRI is available at all of Advanced Radiology’s imaging centers that offer high-strength MRI. Call 888-972-9700 for more information or to make an appointment.
NeuroQuant® is a registered trademark of CorTechs Labs, Inc.